NCT06364449

Brief Summary

Our study aim was to utilize a decision tree analysis (DTA) model to gain insight into the decision-making process within a multiple-center cohort.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 13, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 9, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 15, 2024

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 7, 2024

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
Last Updated

June 19, 2025

Status Verified

May 1, 2025

Enrollment Period

7 months

First QC Date

April 9, 2024

Last Update Submit

June 16, 2025

Conditions

Keywords

Arteriovenous FistulaAV graftHemodialysisdecision tree analysis

Outcome Measures

Primary Outcomes (1)

  • predicted AV access choices

    identifying parameters that predicted AV access choices among the four types

    postoperativ 3 -12 months

Secondary Outcomes (1)

  • to determine factors affecting clinical use of the targeted AV access over a variable timeframe

    postoperativ 3 -12 months

Study Arms (4)

AVF-wrist

Other: No intervention

AVF-elbow

Other: No intervention

AVG-forearm

Other: No intervention

AVG-elbow

Other: No intervention

Interventions

No intervention

AVF-elbowAVF-wristAVG-elbowAVG-forearm

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

chronic kidney disease (CKD) and were in the pre-kidney replacement therapy (pre-KRT) stage, requiring their first hemodialysis (HD) AV access creatio

You may qualify if:

  • \- adult patients between the ages of 18 and 80 who were referred for primary hemodialysis (HD) AV access creation. We included those in the pre-kidney replacement therapy (pre-KRT) stage and those who in the early end-stage kidney disease (ESKD) urgently started HD without sufficient time to plan for AV access

You may not qualify if:

  • \- patients who underwent a secondary AV access surgery, like a transposed radiobasilic AVF or a revision of AVG.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, Taiwan

RECRUITING

MeSH Terms

Conditions

Arteriovenous Fistula

Condition Hierarchy (Ancestors)

Arteriovenous MalformationsVascular MalformationsCardiovascular AbnormalitiesCardiovascular DiseasesVascular FistulaVascular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Chih-Yang Chan, phd

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Chih-Yang Chan, phd

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

April 9, 2024

First Posted

April 15, 2024

Study Start

October 13, 2023

Primary Completion

May 7, 2024

Study Completion

July 31, 2025

Last Updated

June 19, 2025

Record last verified: 2025-05

Locations